Transport of peptidomimetic drugs by the intestinal di/tri-peptide transporter, PepT1

Pharmacology and Toxicology

Volumn 90, Issue 6, 2002, Pages 285-296

  Brodin, Birger ^a   Nielsen, Carsten Uhd ^a   Steffansen, Bente ^a   Frøkjær, Sven ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALENDRONIC ACID; BESTATIN; BETA LACTAM ANTIBIOTIC; BISPHOSPHONIC ACID DERIVATIVE; CARBAPENEM DERIVATIVE; DIPEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRUG CARRIER; GANCICLOVIR; JBP 923; LEVODOPA; METHYLDOPA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NUCLEOSIDE DERIVATIVE; PAMIDRONIC ACID; PD 158473; PEPTIDE; PEPTIDE TRANSPORTER 1; PEPTIDOMIMETIC DRUG; PHENYLALANINE; PHENYLGLYCINE; PRODRUG; PROLINE DERIVATIVE; SERINE DERIVATIVE; TRIPEPTIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALGANCICLOVIR; VALINE; ZIDOVUDINE; CARRIER PROTEIN; COTRANSPORTER; DRUG; OLIGOPEPTIDE; SLC15A1 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APICAL MEMBRANE; BASOLATERAL MEMBRANE; CHEMICAL MODIFICATION; COMPUTER PREDICTION; CONTROLLED STUDY; DIGESTION; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG PROTEIN BINDING; DRUG RESISTANCE; DRUG TRANSPORT; ENZYME ACTIVITY; ENZYME SPECIFICITY; ENZYME SUBSTRATE COMPLEX; HYDROLYSIS; INTESTINE ABSORPTION; INTESTINE CELL; MOLECULAR MODEL; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN INTAKE; PROTEIN STRUCTURE; RAT; SHORT SURVEY; SMALL INTESTINE; STRUCTURE ACTIVITY RELATION; SYSTEMIC CIRCULATION; TRANSPORT KINETICS; ANIMAL; CHEMISTRY; CYTOLOGY; HUMAN; INTESTINE MUCOSA; METABOLISM; MOLECULAR MIMICRY; PHARMACOKINETICS; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

ANIMAL; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; HUMAN; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; MOLECULAR MIMICRY; OLIGOPEPTIDES; PEPTIDES; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; PRODRUGS; ANIMALS; HUMANS; SYMPORTERS;

ANIMALIA;

EID: 0036018543     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2002.900601.x     Document Type: Short Survey

References (135)

1. Characteristics of transmural potential changes associated with the proton-peptide co-transport in toad small intestine
2. A common mechanism for transport of di- and tri-peptides by hamster jejunum in vitro
3. Evidence for active transport of the dipeptide glycylsarcosine by hamster jejunum in vitro
4. The oligopeptide transporter (Pept-1) in human intestine: Biology and function
5. Renal assimilation of oligopeptides: Physiological mechanisms and metabolic importance
6. Intestinal transport of dipeptides in man; relative importance of hydrolysis and intact absorption
7. Electrophysiological analysis of the function of the mammalian renal peptide transporter expressed in Xenopus laevis oocytes
8. Renal excretion of cephapirin and cephaloridine: Evidence for saturable tubular reabsorption
9. Evidence for a glycylproline transport system in ovine enterocyte brush-border membrane vesicles
10. Structural requirements for the intestinal mucosal-cell peptide transporter: The need for N-terminal alpha-amino group
11. How to make drugs orally active: A substrate template for peptide transporter PepT1
12. Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir
13. Evidence for active dipeptide transport in isolated proximal straight tubules
14. Amino acid ester prodrugs of acyclovir
15. Distribution of peptide transporter PEPT2 mRNA in the rat nervous system
16. Alpha(2)-adrenergic receptors stimulate oligopeptide transport in a human intestinal cell line
17. Localization of peptide transporter in nuclei and lysosomes of the pancreas
18. Structure, function, and molecular modeling approaches to the study of the intestinal dipeptide transporter PepT1
19. Expression cloning and functional characterization of the kidney cortex high-affinity proton-coupled peptide transporter
20. Expression cloning of a cDNA from rabbit small intestine related to proton-coupled transport of peptides, beta-lactam antibiotics and ACE-inhibitors
21. Transport of amino acid aryl amides by the intestinal H+/peptide cotransport system, PEPT1
22. A micro-electrode study of oligopeptide absorption by the small intestinal epithelium of Necturus maculosus
23. Decisive structural determinants for the interaction of proline derivatives with the intestinal H+/peptide symporter
24. Expression and protein kinase C-dependent regulation of peptide/H+ co-transport system in the Caco-2 human colon carcinoma cell line
25. Evidence for the absolute conformational specificity of the intestinal H+/peptide symporter, PEPT1
26. Intestinal transport of β-lactam antibiotics: Analysis of the affinity at the H+/peptide symporter (PEPT1), the uptake into caco-2 cell monolayers and the transepithelial flux
27. Intestinal absorption of peptides. Peptide uptake by small intestine of Rana pipiens
28. Tissue distribution of a peptide transporter mRNA in sheep, dairy cows, pigs, and chickens
29. Functional roles of histidine and tyrosine residues in the H(+)-peptide transporter PepT1
30. Function and molecular structure of brush border membrane peptide/H+ symporters
31. Functional separation of dipeptide transport and hydrolysis in kidney brush border membrane vesicles
32. Carrier-mediated uptake of cephalexin in human intestinal cells
33. Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, caco-2
34. Expression and functional characterization of the mammalian intestinal peptide transporter PepT1 in the methylotrophic yeast Pichia pastoris
35. Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications
36. Minimal molecular determinants of substrates for recognition by the intestinal peptide transporter
37. The peptide transporter PepT2 mediates the uptake of the glutathione precursor CysGly in astroglia-rich primary cultures
38. Glycyl-L-proline transport in rabbit enterocyte basolateral-membrane vesicles
39. Regional expression and dietary regulation of rat small intestinal peptide and amino acid transporter mRNAs
40. A peptide prodrug approach for improving bisphosphonate oral absorption
41. Molecular and structural features of the proton-coupled oligopeptide transporter superfamily
42. Expression cloning of a mammalian proton-coupled oligopeptide transporter
43. cDNA structure, genomic organization, and promoter analysis of the mouse intestinal peptide transporter PEPT1
44. Dietary regulation of intestinal transport of the dipeptide carnosine
45. Intestinal absorption mechanism of dipeptide angiotensin converting enzyme inhibitors of the lysyl-proline type: Lisinopril and SQ 29,852
46. Passive and carrier-mediated intestinal absorption components of two angiotensin converting enzyme (ACE) inhibitor prodrugs in rats: Enalapril and fosinopril
47. Receptor ligand-induced up-regulation of the H+/peptide transporter PepT1 in the human intestinal cell line Caco-2
48. Enhancement of the small intestinal uptake of phenylalanylglycine via a H+/oligopeptide transport system by chemical modification with fatty acids
49. Valacyclovir: A substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2
50. Proton-coupled solute transport in the animal cell plasma membrane
51. Dose-dependent absorption and elimination of cefadroxil in man
52. Determining the pharmacophore structure of substrates of the mammalian peptide transporter (PEPT1) by molecular modelling investigations
53. An oligopeptide transporter is expressed at high levels in the pancreatic carcinoma cell lines AsPc-1 and Capan-2
54. Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPepT1) expressed in a mammalian cell line
55. 5′-Amino acid esters of anti-viral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter
56. Structural requirements for interaction with the oligopeptide transporter in Caco-2 cells
57. Mechanisms of glycyl-L-leucine uptake by guinea-pig small intestine: Relative importance of intact-peptide transport
58. Passive and carrier-mediated intestinal absorption components of captopril
59. Use of the peptide carrier system to improve the intestinal absorption of L-alpha-methyldopa: Carrier kinetics, intestinal permeabilities, and in vitro hydrolysis of dipeptidyl derivatives of L-alpha-methyldopa
60. Single-dose pharmacokinetics of valganciclovir in HIV- and CMV- seropositive subjects
61. Regulation of PepT1 peptide transporter expression in the rat small intestine under malnourished conditions
62. + coupled active transport of betastatin via the dipeptide transport system in rabbit intestinal brush-border membranes
63. A novel inhibitor of the mammalian peptide transporter PepT1
64. Interaction of renin inhibitors with the intestinal uptake system for oligopeptides and beta-lactam antibiotics
65. Intestinal ion transport and intracellular pH during acute respiratory alkalosis and acidosis
66. Molecular modeling study of structural requirements for the oligopeptide transporter
67. Human intestinal H+/peptide cotransporter. Cloning, functional expression, and chromosomal localization
68. Hydroxyprolylserine derivatives JBP923 and JNP485 exhibit the antihepatitis activities after gastrointestinal absorption in rats
69. Direct measurement by pH-microelectrode of the pH microclimate in rat proximal jejunum
70. The human intestinal H+/oligopeptide cotransporter hPEPT1 transports differently-charged dipeptides with identical electrogenic properties
71. Intestinal absorption of peptides
72. Mechanisms of peptide transport
73. Structure and function of eukaryotic peptide transporters
74. Modified amino acids and peptides as substrates for the intestinal peptide transporter PepT1
75. Oligopeptides: Mechanism of renal clearance depends on molecular structure
76. A rapid screening system to determine drug affinities for the intestinal dipeptide transporter 2: Affinities of ACE inhibitors
77. Suitability of enalapril as a probe of the dipeptide transporter system: In vitro and in vivo studies
78. Inhibition of the H+/peptide cotransporter in the human intestinal cell line Caco-2 by cyclic AMP
79. Carrier-mediated transport of oligopeptides in the human fibrosarcoma cell line HT1080
80. Cancer cell-targeted drug delivery utilizing oligopeptide transport activity
81. Cellular mechanisms in intestinal transport of amino acids
82. Uptake and transport of the ACE-inhibitor ceranopril (SQ 29852) by monolayers of human intestinal absorptive Caco-2 cells in vitro
83. Epidermal growth factor inhibits glycylsarcosine transport and hPepT1 expression in a human intestinal cell line
84. Dipeptide model prodrugs for the intestinal oligopeptide transporter. Affinity to and transport via hPepT1 in the human intestinal Caco-2 cell line
85. Mechanisms of 5-aminolevulinic acid uptake at the choroid plexus
86. Peptide transporter in the rat small intestine: Ultrastructural localization and the effect of starvation and administration of amino acids
87. Expression of a cloned ovine gastrointestinal peptide transporter (oPepT1) in Xenopus oocytes induces uptake of oligopeptides in vitro
88. Intestinal dipeptidases and the dipeptide transport in the monkey and in man
89. Dipeptide transporters in apical and basolateral membranes of the human intestinal cell line caco-2
90. Cloning and characterization of a rat H+/peptide cotransporter mediating absorption of beta-lactam antibiotics in the intestine and kidney
91. Recognition of L-amino acid ester compounds by rat peptide transporters PEPT1 and PEPT2
92. Cellular and molecular mechanisms of dietary regulation on rat intestinal H+/peptide transporter PepT1
93. H+ gradient-driven dipeptide reabsorption in proximal tubule of rat kidney. Studies in vivo and in vitro
94. Tubular localization and tissue distribution of peptide transporters in rat kidney
95. Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2
96. Evidence for overlapping substrate specificity between large neutral amino acid (LNAA) and dipeptide (hPEPT!) transporters for PD 158473, an NMDA antagonist
97. Mapping the binding site of the small intestinal peptide carrier (PepT1) using comparative molecular field analysis
98. Molecular determinants of recognition for the intestinal peptide carrier
99. Interaction of beta-lactam antibiotics with H+/peptide cotransporters in rat renal brush-border membranes
100. The predominant contribution of oligopeptide transporter PepT1 to intestinal absorption of beta-lactam antibiotics in the rat small intestine
101. Improvement of L-dopa absorption by dipeptidyl derivation, utilizing peptide transporter PepT1
102. Metabolism, uptake, and transepithelial transport of the stereoisomers of Val-Val-Val in the human intestinal cell line, Caco-2
103. Regulation of the PepT1 peptide transporter in the rat small intestine in response to 5-fluorouracil-induced injury
104. Antimicrobial activity of DU-6681a, a parent compound of novel oral carbapenem DZ-2640
105. Beta-Carboxylic acid esterified D-Asp-Ala retains a high affinity for the oligopeptide transporter in Caco-2 monolayers
106. Influence of oligopeptide transporter binding affinity upon uptake and transport of D-Asp(OBzl)-Ala and Asp(OBzl)-Sar in filter-grown Caco-2 monolayers
107. Oligopeptide transporter mediated uptake and transport of d-asp(obzl)-ala, d-glu(obzl)-ala, and d-ser(bzl)-ala in filter-grown caco-2 monolayers
108. Peptide mimics as substrates for the intestinal peptide transporter
109. Recognition of beta-lactam antibiotics by rat peptide transporters, PEPT1 and PEPT2, in LLC-PK1 cells
110. Identification of the histidine residues involved in substrate recognition by a rat H+/peptide cotransporter, PEPT1
111. Functional expression of novel peptide transporter in renal basolateral membranes
112. Functional characteristics of basolateral peptide transporter in the human intestinal cell line Caco-2
113. An active mechanism for completion of the final stage of protein degradation in the liver, lysosomal transport of dipeptides
114. Mechanism of dipeptide stimulation of its own transport in a human intestinal cell line
115. Functional and molecular expression of intestinal oligopeptide transporter (Pept-1) after a brief fast
116. Hormonal regulation of oligopeptide transporter pept-1 in a human intestinal cell line
117. Transepithelial glycylsarcosine transport in intestinal Caco-2 cells mediated by expression of H(+)-coupled carriers at both apical and basal membranes
118. H(+)/solute-induced intracellular acidification leads to selective activation of apical Na(+)/H(+) exchange in human intestinal epithelial cells
119. Transepithelial dipeptide (glycylsarcosine) transport across epithelial monolayers of human Caco-2 cells is rheogenic
120. Mechanism of absorption of the dipeptide alpha-methyldopa-phe in intestinal brush-border membrane vesicles
121. Genomic structure of proton-coupled oligopeptide transporter hPepT1 and pH-sensing regulatory splice variant
122. Characterisation of the H(+)/peptide cotransporter of eel intestinal brush-border membranes
123. Substrate upregulation of the human small intestinal peptide transporter, hPepT1
124. Transepithelial transport properties of peptidomimetic thrombin inhibitors in monolayers of a human intestinal cell line (Caco-2) and their correlation to in vivo data
125. Electrophysiological characteristics of the proton-coupled peptide transporter PEPT2 cloned from rat brain
126. Intestinal absorption studies on peptide mimetic alpha-methyldopa prodrugs
127. In vivo activities of peptidic prodrugs of novel aminomethyl tetrahydrofuranyl-1 beta-methylcarbapenems
128. Transport characteristics of differently charged cephalosporin antibiotics in oocytes expressing the cloned intestinal peptide transporter PepT1 and in human intestinal Caco-2 cells
129. Stereoselective uptake of beta-lactam antibiotics by the intestinal peptide transporter
130. Characteristics of dipeptide transport in pig jejunum in vitro
131. Intestinal peptide transport systems and oral drug availability
132. Molecular identification of a role for tyrosine 167 in the function of the human intestinal proton-coupled dipeptide transporter (hPepT1)
133. Characterisation of an oligopeptide transporter in renal lysosomes
134. Differential recognition of ACE inhibitors in Xenopus Laevis oocytes expressing rat PepT1 and PepT2